2019
DOI: 10.1101/626457
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

RNA polymerase mutations cause cephalosporin resistance in clinicalNeisseria gonorrhoeaeisolates

Abstract: 1The rising incidence of Neisseria gonorrhoeae infection and antimicrobial resistance 2 imperils effective therapy for gonococcal infections 1-4 . Current first-line therapy for gonorrhea 3 relies on ceftriaxone (CRO), an extended spectrum cephalosporin (ESC), as the backbone of 4 treatment. Dual therapy with azithromycin was intended to delay the emergence of resistance, 5 but rising azithromycin resistance rates have been reported 2,5 , resulting in revision of United 6Kingdom treatment guidelines to CRO mon… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
references
References 63 publications
(26 reference statements)
0
0
0
Order By: Relevance